Evidence map›Paper›PMID 34909690›Full record

ArticleJAC-antimicrobial resistance2021

Replacement of

Carolyne Horner, Shazad Mushtaq, Michael Allen, Russell Hope, Sarah Gerver, Christopher Longshaw, Rosy Reynolds, Neil Woodford, David M Livermore

Open access · goldAbstract read
In one paragraph

Article in JAC-antimicrobial resistance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Microbial genomics · 2025
    Article
  6. Vancomycin-ResistantAntibiotics (Basel, Switzerland) · 2025
    Review
  7. Antimicrobial agents and chemotherapy · 2025
    Article
  8. Article
  9. Tracking the Prevalence of Antibiotic Resistance inAntibiotics (Basel, Switzerland) · 2024
    Article
  10. Outcomes ofJAC-antimicrobial resistance · 2024
    Article
  11. Review
  12. Review
  13. Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Observational
  14. Trends inMicroorganisms · 2024
    Article
  15. Article
  16. Article
  17. Genomic insights intoMicrobial genomics · 2023
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Carolyne HornerBritish Society for Antimicrobial Chemotherapy, Birmingham, UK.
Shazad MushtaqUK Health Security Agency, London, UK.
Michael AllenBritish Society for Antimicrobial Chemotherapy, Birmingham, UK.
Russell HopeUK Health Security Agency, London, UK.ORCID https://orcid.org/0000-0003-2838-6833
Sarah GerverUK Health Security Agency, London, UK.
Christopher LongshawBritish Society for Antimicrobial Chemotherapy, Birmingham, UK.
Rosy ReynoldsBristol Medical School, University of Bristol, Bristol, UK.
Neil WoodfordUK Health Security Agency, London, UK.
David M LivermoreNorwich Medical School, University of East Anglia, Norwich, UK.
UK Health Security Agency · GBBritish Society for Antimicrobial Chemotherapy · GBUniversity of Bristol · GBUniversity of East Anglia · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo review temporal changes in the proportions of different

methodsWe reviewed data for enterococci from 2001 to 2019 in: (a) the BSAC Resistance Surveillance Programme, which collected up to 7-10 bloodstream enterococci every year from each of 23-39 hospitals in the UK and Ireland and tested these centrally; and (b) PHE bacteraemia surveillance, using routine results from NHS microbiology laboratories in England.

resultsBSAC surveillance, based upon 206-255 enterococci each year (4486 in total), indicated that the proportion of

conclusionsBoth surveillance systems indicate a growing proportion of

Identifiers

PMID34909690
PMCPMC8664539
OpenAlexW4200501636

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.